- Home
- NUWE vs ALLR Comparison
NUWE vs ALLR Comparison
Compare NUWE & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- ALLR
- Stock Information
- Founded
- NUWE 1999
- ALLR 2004
- Country
- NUWE United States
- ALLR United States
- Employees
- NUWE N/A
- ALLR N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- ALLR Health Care
- Exchange
- NUWE Nasdaq
- ALLR Nasdaq
- Market Cap
- NUWE 5.2M
- ALLR 6.0M
- IPO Year
- NUWE N/A
- ALLR N/A
- Fundamental
- Price
- NUWE $1.27
- ALLR $1.02
- Analyst Decision
- NUWE Strong Buy
- ALLR
- Analyst Count
- NUWE 1
- ALLR 0
- Target Price
- NUWE $17.00
- ALLR N/A
- AVG Volume (30 Days)
- NUWE 1.1M
- ALLR 3.8M
- Earning Date
- NUWE 03-04-2025
- ALLR 03-07-2025
- Dividend Yield
- NUWE N/A
- ALLR N/A
- EPS Growth
- NUWE N/A
- ALLR N/A
- EPS
- NUWE N/A
- ALLR N/A
- Revenue
- NUWE $8,969,000.00
- ALLR N/A
- Revenue This Year
- NUWE $2.18
- ALLR N/A
- Revenue Next Year
- NUWE $25.75
- ALLR N/A
- P/E Ratio
- NUWE N/A
- ALLR N/A
- Revenue Growth
- NUWE 3.66
- ALLR N/A
- 52 Week Low
- NUWE $0.92
- ALLR $0.90
- 52 Week High
- NUWE $27.65
- ALLR $283.20
- Technical
- Relative Strength Index (RSI)
- NUWE 55.34
- ALLR 42.44
- Support Level
- NUWE $1.15
- ALLR $1.00
- Resistance Level
- NUWE $1.67
- ALLR $1.99
- Average True Range (ATR)
- NUWE 0.15
- ALLR 0.22
- MACD
- NUWE 0.01
- ALLR -0.02
- Stochastic Oscillator
- NUWE 36.51
- ALLR 4.43
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.